PFC
Poplar Forest Capital Portfolio holdings
AUM
$563M
1-Year Return
8.43%
This Quarter Return
+5%
1 Year Return
+8.43%
3 Year Return
+29.99%
5 Year Return
+205.2%
10 Year Return
+230.46%
AUM
$937M
AUM Growth
+$144M
(+18%)
Cap. Flow
+$117M
Cap. Flow
% of AUM
12.52%
Top 10 Holdings %
Top 10 Hldgs %
44.49%
Holding
51
New
3
Increased
26
Reduced
7
Closed
2
Top Buys
| 1 |
Halliburton
HAL
|
$30.4M |
| 2 |
Aecom
ACM
|
$19.3M |
| 3 |
AVP
Avon Products, Inc.
AVP
|
$16.6M |
| 4 |
MetLife
MET
|
$14.9M |
| 5 |
URS
URS CORP
URS
|
$9.77M |
Top Sells
| 1 |
Robert Half
RHI
|
$11.4M |
| 2 |
DNY
DONNELLEY R R & SONS CO
DNY
|
$8.57M |
| 3 |
AGN
Allergan plc
AGN
|
$8.45M |
| 4 |
Omnicom Group
OMC
|
$8.26M |
| 5 |
Xerox
XRX
|
$1.63M |
Sector Composition
| 1 | Financials | 31.34% |
| 2 | Technology | 20.16% |
| 3 | Healthcare | 10.74% |
| 4 | Energy | 9.42% |
| 5 | Industrials | 6.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Aecom
ACM
$16.8B
| $19.3M | 2.06% |
+600,061
| New | +$19.3M |
|
|
WPX
27
DELISTED
WPX Energy, Inc.
WPX
| $18.4M | 1.96% |
1,019,602
+206,736
| +25% | +$3.73M |
|
|
AGN
28
DELISTED
Allergan plc
AGN
| $13.5M | 1.44% |
65,527
-41,026
| -39% | -$8.45M |
|
29
Reliance Steel & Aluminium
RS
$15.7B
| $11.6M | 1.23% |
163,738
+20,066
| +14% | +$1.42M |
|
|
URS
30
DELISTED
URS CORP
URS
| $9.77M | 1.04% |
+207,562
| New | +$9.77M |
|
|
DNY
31
DELISTED
DONNELLEY R R & SONS CO
DNY
| $8.96M | 0.96% |
500,341
-478,703
| -49% | -$8.57M |
|
32
Pfizer
PFE
$141B
| $2.68M | 0.29% |
87,988
| – | – |
|
33
Procter & Gamble
PG
$375B
| $2.64M | 0.28% |
32,784
| – | – |
|
34
3M
MMM
$82.7B
| $2.14M | 0.23% |
18,849
| – | – |
|
35
Johnson & Johnson
JNJ
$430B
| $2.02M | 0.22% |
20,579
-1,005
| -5% | -$98.7K |
|
36
Bristol-Myers Squibb
BMY
$96B
| $1.6M | 0.17% |
30,730
-30
| -0.1% | -$1.56K |
|
37
Emerson Electric
EMR
$74.6B
| $1.49M | 0.16% |
22,355
| – | – |
|
38
IBM
IBM
$232B
| $1.17M | 0.12% |
6,339
-115
| -2% | -$21.2K |
|
39
AbbVie
ABBV
$375B
| $976K | 0.1% |
18,990
| – | – |
|
40
Abbott
ABT
$231B
| $731K | 0.08% |
18,990
| – | – |
|
41
GSK
GSK
$81.5B
| $730K | 0.08% |
10,925
| – | – |
|
42
PepsiCo
PEP
$200B
| $681K | 0.07% |
8,160
| – | – |
|
43
Exxon Mobil
XOM
$466B
| $539K | 0.06% |
5,520
| – | – |
|
44
Oracle
ORCL
$654B
| $362K | 0.04% |
8,837
| – | – |
|
45
SPDR S&P 500 ETF Trust
SPY
$660B
| $317K | 0.03% |
1,697
+370
| +28% | +$69.1K |
|
46
Chevron
CVX
$310B
| $301K | 0.03% |
2,528
| – | – |
|
47
Humana
HUM
$37B
| $242K | 0.03% |
2,150
| – | – |
|
|
SNDK
48
DELISTED
SANDISK CORP
SNDK
| $219K | 0.02% |
+2,700
| New | +$219K |
|
49
Progressive
PGR
$143B
| $206K | 0.02% |
8,500
| – | – |
|
|
50
Robert Half
RHI
$3.77B
| – | – |
-270,549
| Closed | -$11.4M |
|